Abstract
Microbial natural products (NPs) represent one of the most successful sources of drugs to treat human diseases. Despite the current need of novel drugs, NPs discovery programs have been gradually abandoned by the big pharma, and smaller biotechnology companies and research organizations are clearly taking the lead in the discovery of novel NPs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
